News

  • Three NWO grants for Leiden researchers exploring the unknown

    Pioneering research at Leiden Faculty of Science awarded NWO grants Three bold ideas, one shared goal: advancing science for a better future From smarter drug delivery to cosmic mysteries and innovative solar energy storage, three researchers from Leiden University’s Faculty…

  • Two new arrivals boost AI and regulatory strength in the park

    From therapeutic mini proteins to pharma compliance services, international life sciences companies are choosing Leiden as the place to grow. Among them are VRG Therapeutics (Hungary) and CONVAL Group (Turkey) — two companies that recently established operations at the Leiden…

  • MIMETAS publishes breakthrough study on human artery-on-a-chip model

    MIMETAS, a leading organ-on-a-chip company, has announced the publication of a new peer-reviewed study that marks a major advance in cardiovascular disease research. The study, titled “Microfluidic artery-on-a-chip model with unidirectional gravity-driven flow for high-throughput applications”, presents a novel 3D…

  • Leiden researchers awarded funding for high-tech research

    Two Leiden University research teams have been awarded grants through the HTSM programme, supporting advanced technology development with strong industry collaborations. DUAL IMPACT, led by Prof. Joost Batenburg (LIACS), aims to transform quality control in industries like food processing and…

  • NecstGen and Astraveus explore benchtop CAR-T manufacturing

    NecstGen has partnered with Paris-based biotech Astraveus to evaluate the Lakhesys™ Benchtop Cell Factory™, a microfluidic-based platform aiming to simplify and scale CAR-T production. The collaboration will test the system’s potential to reduce cost, footprint, and manual steps in a…

  • Trinity College Cambridge Visits Leiden Bio Science Park

    Leiden Bio Science Park welcomed a delegation from Trinity College Cambridge to explore shared innovation goals and strengthen ties between two leading science ecosystems. The visit featured knowledge exchange, campus tours, and conversations on how to grow talent, research, and…

  • Synthetic antibodies that could transform drug development

    What if you could design something that acts like an antibody, but cheaper, more stable, and made entirely with chemistry? Two LACDR researchers, Sebastian Pomplun and Matthias Barz, teamed up to do just that. By merging peptide synthesis with polymer…

  • Life Sciences Cafè- April 2025

    The latest Life Sciences Café at Leiden Bio Science Park brought together students, startups, and seasoned professionals to share ideas and spark collaboration. Inspiring pitches from Sync Biosystems, Constellate Proteomics, and Kedi Bioscience made for a lively and engaging event.